| A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nature medicine 26 (3), 398-407, 2020 | 451 | 2020 |
| Imaging biomarkers in neurodegeneration: current and future practices PNE Young, M Estarellas, E Coomans, M Srikrishna, H Beaumont, ... Alzheimer's Research & Therapy 12, 1-17, 2020 | 161 | 2020 |
| Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study A O’Connor, TK Karikari, T Poole, NJ Ashton, JL Rodriguez, A Khatun, ... Molecular Psychiatry, 1-10, 2020 | 97 | 2020 |
| Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study E Morenas-Rodríguez, Y Li, B Nuscher, N Franzmeier, C Xiong, ... The Lancet Neurology 21 (4), 329-341, 2022 | 95 | 2022 |
| Segregation of functional networks is associated with cognitive resilience in Alzheimer’s disease M Ewers, Y Luan, L Frontzkowski, J Neitzel, A Rubinski, M Dichgans, ... Brain 144 (7), 2176-2185, 2021 | 85 | 2021 |
| Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease PSJ Weston, T Poole, A O’Connor, A Heslegrave, NS Ryan, Y Liang, ... Alzheimer's research & therapy 11, 1-7, 2019 | 81 | 2019 |
| Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease DOT Alawode, AJ Heslegrave, NJ Ashton, TK Karikari, J Simrén, ... Journal of internal medicine 290 (3), 583-601, 2021 | 65 | 2021 |
| Aβ profiles generated by Alzheimer’s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset D Petit, SG Fernández, KM Zoltowska, T Enzlein, NS Ryan, A O’Connor, ... Molecular psychiatry 27 (6), 2821-2832, 2022 | 58 | 2022 |
| Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease‐informed machine‐learning N Franzmeier, N Koutsouleris, T Benzinger, A Goate, CM Karch, ... Alzheimer's & Dementia 16 (3), 501-511, 2020 | 56 | 2020 |
| Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease PR Millar, PH Luckett, BA Gordon, TLS Benzinger, SE Schindler, ... Neuroimage 256, 119228, 2022 | 34 | 2022 |
| Dominantly Inherited Alzheimer, N., 2020. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nat Med 26 (3), 398-407, 0 | 25 | |
| Association of BDNF Val66Met with tau hyperphosphorylation and cognition in dominantly inherited Alzheimer disease YY Lim, P Maruff, NR Barthélemy, A Goate, J Hassenstab, C Sato, ... JAMA neurology 79 (3), 261-270, 2022 | 21 | 2022 |
| Eye-tracking indices of impaired encoding of visual short-term memory in familial Alzheimer’s disease IM Pavisic, Y Pertzov, JM Nicholas, A O’Connor, K Lu, KXX Yong, ... Scientific reports 11 (1), 8696, 2021 | 21 | 2021 |
| Plasma GFAP in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study A O'Connor, E Abel, AL Benedet, T Poole, N Ashton, PSJ Weston, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (1), 90-92, 2023 | 20 | 2023 |
| Longitudinal accumulation of cerebral microhemorrhages in dominantly inherited Alzheimer disease N Joseph-Mathurin, G Wang, K Kantarci, CR Jack Jr, E McDade, ... Neurology 96 (12), e1632-e1645, 2021 | 19 | 2021 |
| Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis A O’Connor, PSJ Weston, IM Pavisic, NS Ryan, JD Collins, K Lu, ... Alzheimer's Research & Therapy 12, 1-9, 2020 | 19 | 2020 |
| Disease duration in autosomal dominant familial Alzheimer disease: A survival analysis IM Pavisic, JM Nicholas, A O'Connor, H Rice, K Lu, NC Fox, NS Ryan Neurology: Genetics 6 (5), e507, 2020 | 19 | 2020 |
| Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept CJ Scott, J Jiao, A Melbourne, N Burgos, DM Cash, E De Vita, ... Journal of Cerebral Blood Flow & Metabolism 39 (12), 2419-2432, 2019 | 18 | 2019 |
| Plasma amyloid-beta ratios in autosomal dominant Alzheimers disease: the influence of genotype A O'Connor, J Pannee, T Poole, C Arber, E Portelius, E Abel, IJ Swift, ... bioRxiv, 2021 | 17 | 2021 |
| Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study AH Boerwinkle, BA Gordon, J Wisch, S Flores, RL Henson, OH Butt, ... The Lancet Neurology 22 (1), 55-65, 2023 | 16 | 2023 |
